Literature DB >> 8616863

Allelic loss on chromosome 10 in prostate adenocarcinoma.

M Ittmann1.   

Abstract

A total of 83 prostate adenocarcinomas was evaluated for allelic loss on chromosome 10 by analysis of loss of polymorphic microsatellite repeats. Initially, 64 stage B carcinomas were analyzed at 12 loci on chromosome 10. Nine cases showed loss of chromosome 10 sequences, with a fractional allelic loss of 20%. These nine cases were then analyzed at an additional 19 loci to define better the regions of loss. Four areas of loss were identified, including 10p (2 of 64 cases), 10q23.1 (7 of 64 cases), 10q23.3 (4 of 64 cases), and 10q26 (2 of 64 cases). Three loci in these regions, D10S111, D10S185, and D10S192, were then analyzed in 19 advanced (stage C and D) carcinomas. Seven (37%) of 19 advanced carcinomas showed allelic loss at one or more of these loci. A statistically significant increase in the fractional allelic loss at both D10S111 (10p) and D10S185 (10q23.1) was observed. Thus, a complex pattern of loss is seen on chromosome 10 in prostate carcinoma, with regions of loss on 10p and 10q, and such loss occurs at a higher rate in clinically advanced disease.

Entities:  

Mesh:

Year:  1996        PMID: 8616863

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  Krüppel cripples prostate cancer: KLF6 progress and prospects.

Authors:  Goutham Narla; Scott L Friedman; John A Martignetti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

3.  Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese.

Authors:  Shusuke Akamatsu; Ryo Takata; Christopher A Haiman; Atsushi Takahashi; Takahiro Inoue; Michiaki Kubo; Mutsuo Furihata; Naoyuki Kamatani; Johji Inazawa; Gary K Chen; Loïc Le Marchand; Laurence N Kolonel; Takahiko Katoh; Yuko Yamano; Minoru Yamakado; Hiroyuki Takahashi; Hiroki Yamada; Shin Egawa; Tomoaki Fujioka; Brian E Henderson; Tomonori Habuchi; Osamu Ogawa; Yusuke Nakamura; Hidewaki Nakagawa
Journal:  Nat Genet       Date:  2012-02-26       Impact factor: 38.330

4.  The gene for human TATA-binding-protein-associated factor (TAFII) 170: structure, promoter and chromosomal localization.

Authors:  J A Van Der Knaap; V Van Den Boom; J Kuipers; M J Van Eijk; P C Van Der Vliet; H T Timmers
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

5.  Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors.

Authors:  D A Deubler; B J Williams; X L Zhu; M R Steele; L R Rohr; J C Jensen; R A Stephenson; J E Changus; G J Miller; M J Becich; A R Brothman
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

6.  Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma.

Authors:  J A Macoska; J Xu; D Ziemnicka; T S Schwab; M A Rubin; L Kotula
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

7.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype.

Authors:  M Longy; V Coulon; B Duboué; A David; M Larrègue; C Eng; P Amati; J L Kraimps; A Bottani; D Lacombe; D Bonneau
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

9.  Mutations and Krüppel-like factor 6 (KLF6) expression levels in breast cancer.

Authors:  Filiz Ozdemir; Mehtap Koksal; Vahit Ozmen; Ibrahim Aydin; Nur Buyru
Journal:  Tumour Biol       Date:  2014-02-12

10.  Chronic chlorpyrifos exposure does not promote prostate cancer in prostate specific PTEN mutant mice.

Authors:  Robert U Svensson; Nadine L Bannick; Maximo J Marin; Larry W Robertson; Charles F Lynch; Michael D Henry
Journal:  J Environ Pathol Toxicol Oncol       Date:  2013       Impact factor: 3.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.